Article Top Ad
Reading Time: 19 minutes

Abstract: Global Diagnostic Imaging Market to Reach US$48. 5 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Diagnostic Imaging estimated at US$33.

New York, July 21, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Diagnostic Imaging Industry” – https://www.reportlinker.com/p05798349/?utm_source=GNW
5 Billion in the year 2020, is projected to reach a revised size of US$48.5 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027.X-ray Imaging, one of the segments analyzed in the report, is projected to grow at a 5.3% CAGR to reach US$15.5 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the MRI segment is readjusted to a revised 5.4% CAGR for the next 7-year period. This segment currently accounts for a 18.9% share of the global Diagnostic Imaging market.

The U.S. Accounts for Over 27.1% of Global Market Size in 2020, While China is Forecast to Grow at a 8.2% CAGR for the Period of 2020-2027

The Diagnostic Imaging market in the U.S. is estimated at US$9.1 Billion in the year 2020. The country currently accounts for a 27.1% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$10.1 Billion in the year 2027 trailing a CAGR of 8.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR while Rest of European market (as defined in the study) will reach US$10.1 Billion by the year 2027.

Ultrasound Segment Corners a 20.8% Share in 2020

In the global Ultrasound segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.3 Billion in the year 2020 will reach a projected size of US$7.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.5 Billion by the year 2027, while Latin America will expand at a 6.1% CAGR through the analysis period.

Select Competitors (Total 66 Featured)

  • Carestream Health, Inc.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

Read the full report: https://www.reportlinker.com/p05798349/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Diagnostic Imaging – A Prelude
Global Diagnostic Imaging Market Set for a Strong Growth
Developed Regions: The Dominant Markets for Diagnostic Imaging
Developing Regions Exhibit the Fastest Growth
Increase in Number of Hospitals & Clinics Infuses Momentum in
Developing Regions
Key Players
Segment Analysis
MRI Dominates the Global Diagnostic Imaging Market
EXHIBIT 1: Equipment Density Correlates With Number of Imaging
Procedures: Magnetic Resonance Imaging (MRI) Units in Select
Countries (Per Million Population) for the Year 2019
Global MRI Market by Application (2019): Percentage Breakdown
of Procedure Volume for Brain, Cardiac & Vascular,
Extremities, Full Body, Mammography, Spine and Others
Computed Tomography System (CT Scanner)
Ultrasound
EXHIBIT 2: Global Ultrasound Systems Market by Portability Type
(2019): Percentage Breakdown of Unit Sales for Cart Systems
and Point-of Care Systems
X-Ray
Nuclear Medicine
SPECT Dominates the Nuclear Medicine Market
Worldwide Installed Base of Nuclear Imaging Equipment by
Modality (2019): Percentage Breakdown of Units Installed for
PET and SPECT
PET————————————————————————————————

2. FOCUS ON SELECT PLAYERS
Agfa-Gevaert N.V. (Belgium
Canon Medical Systems Corporation (Japan)
Carestream Health, Inc. (USA)
Esaote S.p.A. (Italy)
Fujifilm Corporation (Japan)
GE Healthcare (UK)
Koninklijke Philips N.V. (Netherlands)
Konica Minolta Inc. (Japan)
Hitachi Ltd. (Japan)
Hologic, Inc. (USA)
HOYA Group Pentax (Japan)
Samsung Medison Co., Ltd. (Korea)
Shimadzu Corporation (Japan)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China
Siemens Healthineers (Germany)

3. MARKET TRENDS & DRIVERS
Rapidly Growing Geriatric Population and the Rise in Associated
Diseases Catalyze Growth
Rapidly Aging Population Spurs Demand for Diagnostic Imaging:
Global Population of 65+ Individuals (In 000s) by Region for
the Years 2015, 2020, 2025, 2030 & 2050
Rising Incidence of Chronic Diseases Propels the Demand for
Medical Imaging
Rising Prevalence of Chronic Diseases Amplifies the Volume of
Diagnostic Imaging Procedures: Global Cost of Chronic Diseases
(In US$ Billion) for the Years 2018 and 2030
Growing Emphasis on Early Diagnosis is a Driving Factor for
Diagnostic Imaging
Rising Healthcare Expenditure Impels Global Market
Oncology Diagnostic Imaging to Witness Rapid Growth
Global Cancer Incidence by Type: 2018
Technological Innovations Drive the Global Diagnostic Imaging
Market
Growing Adoption of Hybrid Diagnostic Imaging Modalities
PET-CT: The Most Successful Fusion Imaging Technique
SPECT-CT
PET/MRI Continues to Makes Inroads
Ultrasound and MRI Imaging: An Efficient Combination
Rapid Adoption of Contrast-Enhanced Ultrasound (CEUS) Drives
Market Growth
CT Imaging Gains Popularity
CCTA Gaining Traction in Coronary Arteries Imaging
USE OF BLOCKCHAIN IN DIAGNOSTIC IMAGING

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Diagnostic Imaging
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Diagnostic Imaging by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Diagnostic Imaging by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for X-ray Imaging by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for X-ray Imaging by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for X-ray Imaging by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for MRI by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for MRI by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for MRI by Geographic Region –
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Ultrasound by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Ultrasound by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Ultrasound by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for CT by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for CT by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for CT by Geographic Region –
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Nuclear Imaging
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Nuclear Imaging by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Nuclear Imaging by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Hospitals by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Diagnostic
Imaging Centers by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Diagnostic Imaging Centers
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Diagnostic Imaging
Centers by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 25: World Current & Future Analysis for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Diagnostic Imaging
by Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging – Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Diagnostic Imaging by Product –
X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Diagnostic Imaging
by End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Diagnostic Imaging by End-Use –
Hospitals, Diagnostic Imaging Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 43: Japan Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 44: Japan Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

CHINA
Table 46: China Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 49: China Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 50: China Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 51: China 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

EUROPE
Table 52: Europe Current & Future Analysis for Diagnostic
Imaging by Geographic Region – France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 53: Europe Historic Review for Diagnostic Imaging by
Geographic Region – France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Diagnostic Imaging by
Geographic Region – Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 58: Europe Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 59: Europe Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 60: Europe 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

FRANCE
Table 61: France Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 64: France Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 65: France Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 66: France 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 68: Germany Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 70: Germany Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 71: Germany Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 72: Germany 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

ITALY
Table 73: Italy Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 74: Italy Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 76: Italy Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 77: Italy Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 78: Italy 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Diagnostic Imaging
by Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging – Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 80: UK Historic Review for Diagnostic Imaging by Product –
X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 82: UK Current & Future Analysis for Diagnostic Imaging
by End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 83: UK Historic Review for Diagnostic Imaging by End-Use –
Hospitals, Diagnostic Imaging Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 84: UK 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

SPAIN
Table 85: Spain Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 86: Spain Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 87: Spain 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 88: Spain Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 89: Spain Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 90: Spain 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

RUSSIA
Table 91: Russia Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 92: Russia Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 93: Russia 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 94: Russia Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 95: Russia Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 96: Russia 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

REST OF EUROPE
Table 97: Rest of Europe Current & Future Analysis for
Diagnostic Imaging by Product – X-ray Imaging, MRI, Ultrasound,
CT and Nuclear Imaging – Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 98: Rest of Europe Historic Review for Diagnostic Imaging
by Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 99: Rest of Europe 15-Year Perspective for Diagnostic
Imaging by Product – Percentage Breakdown of Value Sales for
X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the
Years 2012, 2020 & 2027

Table 100: Rest of Europe Current & Future Analysis for
Diagnostic Imaging by End-Use – Hospitals, Diagnostic Imaging
Centers and Other End-Uses – Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 101: Rest of Europe Historic Review for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses Markets – Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 102: Rest of Europe 15-Year Perspective for Diagnostic
Imaging by End-Use – Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Imaging Centers and Other End-Uses for
the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 103: Asia-Pacific Current & Future Analysis for
Diagnostic Imaging by Geographic Region – Australia, India,
South Korea and Rest of Asia-Pacific Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 104: Asia-Pacific Historic Review for Diagnostic Imaging
by Geographic Region – Australia, India, South Korea and Rest
of Asia-Pacific Markets – Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 105: Asia-Pacific 15-Year Perspective for Diagnostic
Imaging by Geographic Region – Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 106: Asia-Pacific Current & Future Analysis for
Diagnostic Imaging by Product – X-ray Imaging, MRI, Ultrasound,
CT and Nuclear Imaging – Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 107: Asia-Pacific Historic Review for Diagnostic Imaging
by Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 108: Asia-Pacific 15-Year Perspective for Diagnostic
Imaging by Product – Percentage Breakdown of Value Sales for
X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the
Years 2012, 2020 & 2027

Table 109: Asia-Pacific Current & Future Analysis for
Diagnostic Imaging by End-Use – Hospitals, Diagnostic Imaging
Centers and Other End-Uses – Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: Asia-Pacific Historic Review for Diagnostic Imaging
by End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 111: Asia-Pacific 15-Year Perspective for Diagnostic
Imaging by End-Use – Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Imaging Centers and Other End-Uses for
the Years 2012, 2020 & 2027

AUSTRALIA
Table 112: Australia Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 113: Australia Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 114: Australia 15-Year Perspective for Diagnostic Imaging
by Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 115: Australia Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 116: Australia Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 117: Australia 15-Year Perspective for Diagnostic Imaging
by End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

INDIA
Table 118: India Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 119: India Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 120: India 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 121: India Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 122: India Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 123: India 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

SOUTH KOREA
Table 124: South Korea Current & Future Analysis for Diagnostic

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05798349/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

CONTACT: Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

Powered by WPeMatico